Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|October 9, 2014
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal diseaseDavid CharytanNephrology (Carlton, Vic.)|March 12, 2004
Severe metabolic complications from theophylline intoxicationDavid Charytan, Kevin JansenClinical Medicine Insights. Cardiology|December 21, 2020
Cardiovascular Issues Among Homeless People: An Issue that Needs AttentionMuhammad Haisum Maqsood, Omer Kamal, David CharytanNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2007
Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney diseaseDavid Charytan, John P Forman, Donald E CutlipAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2007
Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patientsDavid Charytan, Richard E Kuntz, Laura Mauri, et al.American Heart Journal|August 23, 2006
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patientsDavid Charytan, Laura Mauri, Anupam Agarwal, et al.Journal of Nephrology|September 15, 2004
Allograft rejection and glomerular basement membrane antibodies in Alport's syndromeDavid Charytan, Adriana Torre, Mona Khurana, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 5, 2005
An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodiesDavid Charytan, Brian MacDonald, Hikaru Sugimoto, et al.The Journal of Biological Chemistry|January 23, 2003
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuriaHikaru Sugimoto, Yuki Hamano, David Charytan, et al.Nature Medicine|June 17, 2003
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injuryMichael Zeisberg, Jun-ichi Hanai, Hikaru Sugimoto, et al.Pageof 2